Tumor-infiltrating lymphocyte as a prognostic biomarker in stage IV colorectal cancer should take into account the metastatic status and operation modality

被引:19
|
作者
Xie, Qian-Kun [1 ]
He, Wen-Zhuo [1 ]
Hu, Wan-Ming [2 ,3 ,4 ]
Yang, Lin [1 ]
Jiang, Chang [1 ]
Kong, Peng-Fei [1 ]
Yang, Yuan-Zhong [2 ]
Yang, Qiong [1 ,5 ]
Zhang, Hui-Zhong [2 ]
Zhang, Bei [1 ]
Xia, Liang-Ping [1 ]
机构
[1] Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, VIP Reg State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept Pathol,State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China
[3] Southern Med Univ, Sch Basic Med Sci, Dept Pathol, Guangzhou, Guangdong, Peoples R China
[4] Southern Med Univ, Dept Pathol, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China
[5] Sun Yat Sen Mem Hosp, Dept Oncol, Guangzhou, Guangdong, Peoples R China
来源
CANCER MANAGEMENT AND RESEARCH | 2018年 / 10卷
基金
中国国家自然科学基金;
关键词
colorectal cancer; stage IV; tumor-infiltrating lymphocytes; metastatic status; survival; MOLECULAR-BASIS; BREAST-CANCER; PATTERN;
D O I
10.2147/CMAR.S162147
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Although tumor-infiltrating lymphocytes (TILs) have been understood for years as a favorable prognostic factor for colorectal cancers (CRCs) after complete surgical resection, its prognostic role in metastatic CRC (mCRC) remains poorly defined, and it is largely unknown how this prognostic benefit relates to the metastatic status and operation modality. Materials and methods: After reviewing 2215 consecutive cases of surgically resected CRC, 332 patients newly diagnosed with stage IV CRC and treated at the Sun Yat-Sen University Cancer Center between 2009 and 2014 were included. H&E-stained (HES) slides from surgical specimens were evaluated for the extent of TILs. The primary end point was overall survival (OS). Cox proportional hazards regression was conducted to determine the prognostic significance of TILs. All statistical tests were 2-sided. Results: HES slides from primary tumor samples were evaluable for 302 of the 332 included cases. Among the 302 patients, 105 patients (34.8%) were classified as high TIL, the remaining 197 (65.2%) were defined as low TIL. In the univariate analysis, TILs were significantly associated with better OS (P=0.015). Multivariable analysis confirmed that high TIL strongly predicted better survival (hazard ratio =0.62, 95% CI: 0.44-0.89, P=0.008), independent of other patients' clinicopathological characteristics. Stratified analysis revealed a prognostic benefit of high TIL for patients in the subgroup with non-oligometastatic disease (P=0.002), >= 2 metastatic organs (P=0.006), and non-metastasectomy (P=0.005). By contrast, oligometastatic disease, 1 metastatic organ, or metastasectomy fully abrogated the prognostic effect of TIL. Conclusion: Our findings indicate that the level of TILs can be used to predict the outcome for patients with mCRC; however, the operation modality and the metastatic status of patients should also be taken into account.
引用
收藏
页码:1365 / 1375
页数:11
相关论文
共 50 条
  • [31] The combination of CDX2 expression status and tumor-infiltrating lymphocyte density as a prognostic factor in adjuvant FOLFOX-treated patients with stage III colorectal cancers
    Lee, Ji-Ae
    Park, Hye Eun
    Jin, Hye-Yeong
    Jin, Lingyan
    Yoo, Seung Yeon
    Cho, Nam-Yun
    Bae, Jeong Mo
    Kim, Jung Ho
    Kang, Gyeong Hoon
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2025, 59 (01) : 50 - 59
  • [32] Tumor-infiltrating B cells as a favorable prognostic biomarker in breast cancer: a systematic review and meta-analysis
    Qin, You
    Peng, Fei
    Ai, Lisha
    Mu, Shidai
    Li, Yuting
    Yang, Chensu
    Hu, Yu
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [33] Comparison of the prognostic value of stromal tumor-infiltrating lymphocytes and CD3+T cells between schistosomal and non-schistosomal colorectal cancer
    Wang, Weixia
    Zhang, Yingyi
    Liu, Jican
    Jing, Hongyan
    Lu, Kui
    Wang, Limei
    Zhu, Ting
    Xu, Yanchao
    Bu, Dacheng
    Cheng, Meihong
    Liu, Jing
    Shen, Weidong
    Yao, Junxia
    Huang, Sinian
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2023, 21 (01)
  • [34] Prognostic value of tumor-infiltrating lymphocyte subtypes and microorganisms in triple-negative breast cancer
    Shi, Yating
    Guo, Zhi
    Wang, Qiang
    Deng, Huan
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2024, 20 (07) : 1983 - 1990
  • [35] ITGAE Defines CD8+ Tumor-Infiltrating Lymphocytes Predicting a better Prognostic Survival in Colorectal Cancer
    Hu, Xiang
    Li, Ya-Qi
    Li, Qing-Guo
    Ma, Yan-Lei
    Peng, Jun-Jie
    Cai, San-Jun
    EBIOMEDICINE, 2018, 35 : 178 - 188
  • [36] Association of tumor budding with clinicopathological features and prognostic value in stage III-IV colorectal cancer
    Luo, Yue-Hao
    Yan, Zhe-Cheng
    Liu, Jia-Ying
    Li, Xin-Yi
    Yang, Ming
    Fan, Jun
    Huang, Bo
    Ma, Cheng-Gong
    Chang, Xiao-Na
    Nie, Xiu
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (02) : 158 - 169
  • [37] Prognostic Implications of Intratumoral Budding in Colorectal Cancer: Detailed Analysis Based on Tumor-Infiltrating Lymphocytes
    Pyo, Jung-Soo
    Choi, Ji Eun
    Kim, Nae Yu
    Min, Kyueng-Whan
    Kang, Dong-Wook
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (01)
  • [38] Prognostic utility of circulating tumor DNA methylation analysis in stage IV colorectal cancer
    Momose, Hirotaka
    Sugimoto, Kiichi
    Irie, Takahiro
    Nomura, Sachio
    Ro, Hisashi
    Ishiyama, Shun
    Takahashi, Makoto
    Pisanic, Thomas
    Sakamoto, Kazuhiro
    JOURNAL OF SURGICAL ONCOLOGY, 2024, : 160 - 169
  • [39] Changes and prognostic values of tumor-infiltrating lymphocyte subsets after primary systemic therapy in breast cancer
    Ahn, Soomin
    Chung, Yul Ri
    Seo, An Na
    Kim, Milim
    Woo, Ji Won
    Park, So Yeon
    PLOS ONE, 2020, 15 (05):
  • [40] Artificial intelligence-based analysis of tumor-infiltrating lymphocyte spatial distribution for colorectal cancer prognosis
    Cai, Ming
    Zhao, Ke
    Wu, Lin
    Huang, Yanqi
    Zhao, Minning
    Hu, Qingru
    Chen, Qicong
    Yao, Su
    Li, Zhenhui
    Fan, Xinjuan
    Liu, Zaiyi
    CHINESE MEDICAL JOURNAL, 2024, 137 (04) : 421 - 430